Biodesix Inc is a diagnostics & research business based in the US. Biodesix shares (BDSX) are listed on the NASDAQ and all prices are listed in US Dollars. Biodesix employs 200 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Biodesix
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BDSX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Biodesix stock price (NASDAQ: BDSX)Use our graph to track the performance of BDSX stocks over time.
Biodesix shares at a glance
|Latest market close||$4.75|
|52-week range||$4.02 - $31.99|
|50-day moving average||$5.99|
|200-day moving average||$10.57|
|Wall St. target price||$16.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.36|
Buy Biodesix shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Biodesix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Biodesix price performance over time
|1 week (2022-01-10)||-16.67%|
|1 month (2021-12-17)||-1.86%|
|3 months (2021-10-15)||-36.67%|
|6 months (2021-07-16)||-58.37%|
|1 year (2021-01-15)||-83.04%|
|2 years (2020-01-13)||N/A|
|3 years (2019-01-13)||N/A|
|5 years (2017-01-13)||N/A|
|Revenue TTM||$74.3 million|
|Gross profit TTM||$23.6 million|
|Return on assets TTM||-27.86%|
|Return on equity TTM||-1089.34%|
|Market capitalisation||$175.5 million|
TTM: trailing 12 months
Biodesix share dividends
We're not expecting Biodesix to pay a dividend over the next 12 months.
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; and GeneStrat tumor profiling and VeriStrat immune profiling tests that provide physicians with timely results to facilitate treatment decisions. It also provides Bio-Rad SARS-CoV-2 ddPCR test, which is designed to detect the presence of infection by the SARS-CoV-2 virus; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. In addition, the company offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc.
Biodesix in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda
Frequently asked questionsWhat percentage of Biodesix is owned by insiders or institutions?
Currently 75.152% of Biodesix shares are held by insiders and 15.821% by institutions. How many people work for Biodesix?
Latest data suggests 200 work at Biodesix. When does the fiscal year end for Biodesix?
Biodesix's fiscal year ends in December. Where is Biodesix based?
Biodesix's address is: 2970 Wilderness Place, Boulder, CO, United States, 80301 What is Biodesix's ISIN number?
Biodesix's international securities identification number is: US09075X1081
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert